BridgeBio Pharma (BBIO) Share-based Compensation Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 28.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.44% |
| Dec 31, 2025 | 14.98% |
| Sep 30, 2025 | 29.97% |
| Jun 30, 2025 | 74.07% |
| Mar 31, 2025 | -10.29% |
| Dec 31, 2024 | -18.63% |
| Sep 30, 2024 | -0.36% |
| Jun 30, 2024 | -21.07% |
| Mar 31, 2024 | 31.69% |
| Dec 31, 2023 | 82.25% |
| Sep 30, 2023 | 45.94% |
| Jun 30, 2023 | -3.99% |
| Mar 31, 2023 | -9.78% |
| Dec 31, 2022 | -9.76% |
| Sep 30, 2022 | 15.67% |
| Jun 30, 2022 | -11.64% |
| Mar 31, 2022 | -30.42% |
| Dec 31, 2021 | 85.35% |
| Sep 30, 2021 | -8.86% |
| Jun 30, 2021 | 74.18% |
| Mar 31, 2021 | 241.38% |
| Dec 31, 2020 | 21.38% |
| Sep 30, 2020 | 206.37% |
| Jun 30, 2020 | 447.71% |
| Mar 31, 2020 | 357.97% |
| Dec 31, 2019 | 221.46% |
| Sep 30, 2019 | 1,825.67% |
| Jun 30, 2019 | 3,258.00% |